Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Liothyronine sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for liothyronine sodium and what is the scope of liothyronine sodium patent protection?

Liothyronine sodium
is the generic ingredient in three branded drugs marketed by Par Sterile Products, X Gen Pharms, Mylan, Watson Labs, King Pharms, Sun Pharm Inds Ltd, Sigmapharm Labs Llc, and Mayne Pharma Inc, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for liothyronine sodium. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: liothyronine sodium

Drug Master File Entries: see list4
Suppliers / Packagers: see list22
Bulk Api Vendors: see list74
Clinical Trials: see list931
Patent Applications: see list1,103
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:liothyronine sodium at DailyMed

Pharmacology for Ingredient: liothyronine sodium

Drug Classl-Triiodothyronine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
liothyronine sodium
TABLET;ORAL091382-003Apr 20, 2016ABRXNoNo► Subscribe► Subscribe
liothyronine sodium
TABLET;ORAL090326-003Jul 14, 2009ABRXNoNo► Subscribe► Subscribe
Sigmapharm Labs Llc
liothyronine sodium
TABLET;ORAL200295-002Nov 29, 2012ABRXNoNo► Subscribe► Subscribe
liothyronine sodium
TABLET;ORAL090326-001Jul 14, 2009ABRXNoNo► Subscribe► Subscribe
Sigmapharm Labs Llc
liothyronine sodium
TABLET;ORAL200295-003Nov 29, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus